Weaker Control of the Electrical Properties of Cerebellar Granule Cells by Tonically Active GABAA Receptors in the Ts65Dn Mouse Model of Down's Syndrome

Overview

Journal Mol Brain

Publisher Biomed Central

Specialties Molecular Biology
Neurology

Date 2013 Jul 23

PMID 23870245

Citations 6

Authors

Marianna Szemes

Rachel L Davies

Claire Lp Garden

Maria M Usowicz

Affiliations

Soon will be listed here.

Abstract

Background: Down's syndrome (DS) is caused by triplication of all or part of human chromosome 21 and is characterized by a decrease in the overall size of the brain. One of the brain regions most affected is the cerebellum, in which the number of granule cells (GCs) is markedly decreased. GCs process sensory information entering the cerebellum via mossy fibres and pass it on to Purkinje cells and inhibitory interneurons. How GCs transform incoming signals depends on their input-output relationship, which is adjusted by tonically active GABA(A) receptor channels.

Results: We report that in the Ts65Dn mouse model of DS, in which cerebellar volume and GC number are decreased as in DS, the tonic GABA(A) receptor current in GCs is smaller than in wild-type mice and is less effective in moderating input resistance and raising the minimum current required for action potential firing. We also find that tonically active GABA(A) receptors curb the height and broaden the width of action potentials in wild-type GCs but not in Ts65Dn GCs. Single-cell real-time quantitative PCR reveals that these electrical differences are accompanied by decreased expression of the gene encoding the GABA(A) receptor β3 subunit but not genes coding for some of the other GABA(A) receptor subunits expressed in GCs (α1, α6, β2 and δ).

Conclusions: Weaker moderation of excitability and action potential waveform in GCs of the Ts65Dn mouse by tonically active GABA(A) receptors is likely to contribute to atypical transfer of information through the cerebellum. Similar changes may occur in DS.

Citing Articles

Tonic GABA Conductance Favors Spike-Timing-Dependent over Theta-Burst-Induced Long-Term Potentiation in the Hippocampus.

Dembitskaya Y, Wu Y, Semyanov A J Neurosci. 2020; 40(22):4266-4276.

PMID: 32327534 PMC: 7252479. DOI: 10.1523/JNEUROSCI.2118-19.2020.

Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models.

Souchet B, Duchon A, Gu Y, Dairou J, Chevalier C, Daubigney F Sci Rep. 2019; 9(1):3914.

PMID: 30850713 PMC: 6408590. DOI: 10.1038/s41598-019-40328-9.

A third copy of the Down syndrome cell adhesion molecule (Dscam) causes synaptic and locomotor dysfunction in Drosophila.

Lowe S, Hodge J, Usowicz M Neurobiol Dis. 2017; 110:93-101.

PMID: 29196216 PMC: 5773243. DOI: 10.1016/j.nbd.2017.11.013.

Decreasing the Expression of GABA α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome.

Vidal V, Garcia-Cerro S, Martinez P, Corrales A, Lantigua S, Vidal R Mol Neurobiol. 2017; 55(6):4745-4762.

PMID: 28717969 DOI: 10.1007/s12035-017-0675-3.

The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome.

Contestabile A, Magara S, Cancedda L Front Cell Neurosci. 2017; 11:54.

PMID: 28326014 PMC: 5339239. DOI: 10.3389/fncel.2017.00054.

References

Das I, Reeves R . The use of mouse models to understand and improve cognitive deficits in Down syndrome. Dis Model Mech. 2011; 4(5):596-606. PMC: 3180223. DOI: 10.1242/dmm.007716. View

Seja P, Schonewille M, Spitzmaul G, Badura A, Klein I, Rudhard Y . Raising cytosolic Cl- in cerebellar granule cells affects their excitability and vestibulo-ocular learning. EMBO J. 2012; 31(5):1217-30. PMC: 3297995. DOI: 10.1038/emboj.2011.488. View

Arenz A, Bracey E, Margrie T . Sensory representations in cerebellar granule cells. Curr Opin Neurobiol. 2009; 19(4):445-51. DOI: 10.1016/j.conb.2009.07.003. View

Stell B, Brickley S, Tang C, Farrant M, Mody I . Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors. Proc Natl Acad Sci U S A. 2003; 100(24):14439-44. PMC: 283610. DOI: 10.1073/pnas.2435457100. View

Costa A, Grybko M . Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of Down syndrome. Neurosci Lett. 2005; 382(3):317-22. DOI: 10.1016/j.neulet.2005.03.031. View

Liu D, Schmidt C, Billings T, Davisson M . Quantitative PCR genotyping assay for the Ts65Dn mouse model of Down syndrome. Biotechniques. 2003; 35(6):1170-4, 1176, 1178 passim. DOI: 10.2144/03356st02. View

Reeves R, Irving N, Moran T, WOHN A, Kitt C, Sisodia S . A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet. 1995; 11(2):177-84. DOI: 10.1038/ng1095-177. View

Semyanov A, Walker M, Kullmann D . GABA uptake regulates cortical excitability via cell type-specific tonic inhibition. Nat Neurosci. 2003; 6(5):484-90. DOI: 10.1038/nn1043. View

Jernigan T, Bellugi U . Anomalous brain morphology on magnetic resonance images in Williams syndrome and Down syndrome. Arch Neurol. 1990; 47(5):529-33. DOI: 10.1001/archneur.1990.00530050049011. View

10.

Escorihuela R, Fernandez-Teruel A, Vallina I, Baamonde C, Lumbreras M, Dierssen M . A behavioral assessment of Ts65Dn mice: a putative Down syndrome model. Neurosci Lett. 1995; 199(2):143-6. DOI: 10.1016/0304-3940(95)12052-6. View

11.

Aylward E, Habbak R, Warren A, Pulsifer M, Barta P, Jerram M . Cerebellar volume in adults with Down syndrome. Arch Neurol. 1997; 54(2):209-12. DOI: 10.1001/archneur.1997.00550140077016. View

12.

Khoshnood B, Greenlees R, Loane M, Dolk H . Paper 2: EUROCAT public health indicators for congenital anomalies in Europe. Birth Defects Res A Clin Mol Teratol. 2011; 91 Suppl 1:S16-22. PMC: 3320858. DOI: 10.1002/bdra.20776. View

13.

Somogyi P, Fritschy J, Benke D, Roberts J, Sieghart W . The gamma 2 subunit of the GABAA receptor is concentrated in synaptic junctions containing the alpha 1 and beta 2/3 subunits in hippocampus, cerebellum and globus pallidus. Neuropharmacology. 1996; 35(9-10):1425-44. DOI: 10.1016/s0028-3908(96)00086-x. View

14.

Edgin J, Mason G, Spano G, Fernandez A, Nadel L . Human and mouse model cognitive phenotypes in Down syndrome: implications for assessment. Prog Brain Res. 2012; 197:123-51. DOI: 10.1016/B978-0-444-54299-1.00007-8. View

15.

Harashima C, Jacobowitz D, Stoffel M, Chakrabarti L, Haydar T, Siarey R . Elevated expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in cerebellar unipolar brush cells of a Down syndrome mouse model. Cell Mol Neurobiol. 2006; 26(4-6):719-34. PMC: 11520672. DOI: 10.1007/s10571-006-9066-4. View

16.

Letourneau A, Antonarakis S . Genomic determinants in the phenotypic variability of Down syndrome. Prog Brain Res. 2012; 197:15-28. DOI: 10.1016/B978-0-444-54299-1.00002-9. View

17.

Friedman R, Farh K, Burge C, Bartel D . Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2008; 19(1):92-105. PMC: 2612969. DOI: 10.1101/gr.082701.108. View

18.

Tia S, Wang J, Kotchabhakdi N, Vicini S . Developmental changes of inhibitory synaptic currents in cerebellar granule neurons: role of GABA(A) receptor alpha 6 subunit. J Neurosci. 1996; 16(11):3630-40. PMC: 6578841. View

19.

Bhattacharyya A, McMillan E, Chen S, Wallace K, Svendsen C . A critical period in cortical interneuron neurogenesis in down syndrome revealed by human neural progenitor cells. Dev Neurosci. 2009; 31(6):497-510. PMC: 2818457. DOI: 10.1159/000236899. View

20.

Santhakumar V, Hanchar H, Wallner M, Olsen R, Otis T . Contributions of the GABAA receptor alpha6 subunit to phasic and tonic inhibition revealed by a naturally occurring polymorphism in the alpha6 gene. J Neurosci. 2006; 26(12):3357-64. PMC: 2247415. DOI: 10.1523/JNEUROSCI.4799-05.2006. View